What is Haemonetics's AOCI?

Haemonetics (HAE) reported AOCI of -$37.61M in Q1 2026.

How has Haemonetics's AOCI changed year-over-year?

Haemonetics's AOCI increased by 31.7% year-over-year, from -$55.08M to -$37.61M.

What is the long-term trend for Haemonetics's AOCI?

Over 5 years (2021 to 2026), Haemonetics's AOCI has grown at a 4.9% compound annual growth rate (CAGR), from -$29.55M to -$37.61M.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Haemonetics HAE AOCI

AOCI at other companies

AbbottABT

-$6.31B+14.9%

TFX

TeleflexTFX

-$239.47M+24.4%

Boston ScientificBSX

-$398M-1,321%

MedtronicMDT

-$4.1B+4.3%

LivaNovaLIVN

-$3.4M+92.0%

ICU MedicalICUI

-$51.9M+50.8%

Other financials

Income statement

See full

Revenue$346.4M+4.8%

Gross profit$198.2M+2.7%

Operating income$67.4M+14.2%

Net income$44.7M+19.3%

EPS (diluted)$0.95+28.4%

Balance sheet

See full

Cash & equivalents$245.4M-20.0%

Total debt$1.3B-0.7%

Total equity$796.3M-3.0%

Total assets$2.4B-2.2%

Cash flow

See full

Operating cash flow$70.9M-39.1%

CapEx$17.7M+12.9%

Free cash flow$53.3M-47.2%

Valuation

See full

Market cap$3.31B-18.0%

Profitability

See full

Gross margin59%+4.0pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin19.5%+9.1pp

Returns & leverage

See full

Return on equity19.3%+5.2pp

Debt / equity1.6×0.0×

Current ratio3×+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Haemonetics's AOCI?: Haemonetics (HAE) reported AOCI of -$37.61M in Q1 2026.
How has Haemonetics's AOCI changed year-over-year?: Haemonetics's AOCI increased by 31.7% year-over-year, from -$55.08M to -$37.61M.
What is the long-term trend for Haemonetics's AOCI?: Over 5 years (2021 to 2026), Haemonetics's AOCI has grown at a 4.9% compound annual growth rate (CAGR), from -$29.55M to -$37.61M.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.